CY1105228T1 - Φαρμακευτικο αιωρημα πepιλαμβανον ημι-ενυδρη νεβιραπινη - Google Patents

Φαρμακευτικο αιωρημα πepιλαμβανον ημι-ενυδρη νεβιραπινη

Info

Publication number
CY1105228T1
CY1105228T1 CY20061101147T CY061101147T CY1105228T1 CY 1105228 T1 CY1105228 T1 CY 1105228T1 CY 20061101147 T CY20061101147 T CY 20061101147T CY 061101147 T CY061101147 T CY 061101147T CY 1105228 T1 CY1105228 T1 CY 1105228T1
Authority
CY
Cyprus
Prior art keywords
pepilamvanone
nebirapine
hydric
semi
pharmaceutical suspension
Prior art date
Application number
CY20061101147T
Other languages
English (en)
Inventor
Karl Georg Grozinger
Amale A. Hawi
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1105228(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharmaceuticals Inc. filed Critical Boehringer Ingelheim Pharmaceuticals Inc.
Publication of CY1105228T1 publication Critical patent/CY1105228T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Υδατικό φαρμακευτικό αιώρημα αποτελούμενο ουσιαστικώς από ημι-ένυδρη νεβιραπίνη έχουσα διάμετρο σωματιδίων μεγέθους από 1 έως 150 μm περίπου.
CY20061101147T 1997-08-25 2006-08-11 Φαρμακευτικο αιωρημα πepιλαμβανον ημι-ενυδρη νεβιραπινη CY1105228T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25
PCT/US1998/016581 WO1999009990A1 (en) 1997-08-25 1998-08-11 Pharmaceutical suspension comprising nevirapine hemihydrate

Publications (1)

Publication Number Publication Date
CY1105228T1 true CY1105228T1 (el) 2010-03-03

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101147T CY1105228T1 (el) 1997-08-25 2006-08-11 Φαρμακευτικο αιωρημα πepιλαμβανον ημι-ενυδρη νεβιραπινη

Country Status (38)

Country Link
US (2) US6172059B1 (el)
EP (1) EP1019058B1 (el)
JP (1) JP3472261B2 (el)
KR (1) KR100426516B1 (el)
CN (1) CN1197578C (el)
AR (2) AR016869A1 (el)
AT (1) ATE326971T1 (el)
AU (1) AU742761B2 (el)
BG (1) BG64337B1 (el)
BR (1) BR9811994B1 (el)
CA (1) CA2301646C (el)
CL (1) CL2008003111A1 (el)
CO (1) CO4970742A1 (el)
CY (1) CY1105228T1 (el)
CZ (1) CZ290667B6 (el)
DE (1) DE69834655T2 (el)
DK (1) DK1019058T3 (el)
EG (1) EG24075A (el)
ES (1) ES2265666T3 (el)
HK (1) HK1027975A1 (el)
HR (1) HRP980461B1 (el)
HU (1) HU226063B1 (el)
ID (1) ID21650A (el)
IL (1) IL134185A (el)
MY (1) MY122272A (el)
NO (1) NO326226B1 (el)
NZ (1) NZ503414A (el)
PE (1) PE105799A1 (el)
PL (1) PL192361B1 (el)
PT (1) PT1019058E (el)
RS (1) RS49808B (el)
RU (1) RU2196584C2 (el)
SA (1) SA98190680B1 (el)
TR (1) TR200000490T2 (el)
TW (1) TW450812B (el)
UA (1) UA44370C2 (el)
WO (1) WO1999009990A1 (el)
ZA (1) ZA987623B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
WO2003091290A1 (en) * 2002-04-23 2003-11-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for reduction of residual organic solvent in carbomer
ATE484284T1 (de) * 2005-08-31 2010-10-15 Cipla Ltd Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin
WO2010006697A2 (en) * 2008-06-30 2010-01-21 Tibotec Pharmaceuticals Powders for reconstitution
DE112010004065T5 (de) * 2009-11-10 2012-10-25 North West University Verfahren zur Erhöhung der Löslichkeit einer Transkriptaseinhibitor-Zusammensetzung
CN102725293A (zh) * 2009-12-17 2012-10-10 西北大学 奈韦拉平的多晶型形式及其制备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
ID21650A (id) 1999-07-08
ATE326971T1 (de) 2006-06-15
AU742761B2 (en) 2002-01-10
CZ290667B6 (cs) 2002-09-11
BR9811994B1 (pt) 2013-11-19
AR083451A2 (es) 2013-02-27
NZ503414A (en) 2002-11-26
AR016869A1 (es) 2001-08-01
PL192361B1 (pl) 2006-10-31
TW450812B (en) 2001-08-21
UA44370C2 (uk) 2002-02-15
MY122272A (en) 2006-04-29
HRP980461A2 (en) 1999-06-30
EP1019058B1 (en) 2006-05-24
YU9800A (sh) 2001-12-26
EG24075A (en) 2008-05-11
HUP0003093A2 (hu) 2001-08-28
HRP980461B1 (en) 2002-08-31
US6172059B1 (en) 2001-01-09
KR20010023257A (ko) 2001-03-26
PL338828A1 (en) 2000-11-20
RS49808B (sr) 2008-08-07
NO20000906L (no) 2000-02-24
NO20000906D0 (no) 2000-02-24
CZ2000694A3 (cs) 2000-09-13
DE69834655D1 (de) 2006-06-29
KR100426516B1 (ko) 2004-04-13
CA2301646A1 (en) 1999-03-04
CA2301646C (en) 2008-11-18
BG64337B1 (bg) 2004-10-29
HU226063B1 (hu) 2008-04-28
CO4970742A1 (es) 2000-11-07
IL134185A0 (en) 2001-04-30
SA98190680B1 (ar) 2006-04-04
RU2196584C2 (ru) 2003-01-20
NO326226B1 (no) 2008-10-20
PT1019058E (pt) 2006-08-31
CL2008003111A1 (es) 2009-09-11
PE105799A1 (es) 1999-11-16
ES2265666T3 (es) 2007-02-16
EP1019058A1 (en) 2000-07-19
WO1999009990A1 (en) 1999-03-04
US6255481B1 (en) 2001-07-03
JP2001513564A (ja) 2001-09-04
HK1027975A1 (en) 2001-02-02
EP1019058A4 (en) 2004-11-10
DE69834655T2 (de) 2006-12-14
CN1268055A (zh) 2000-09-27
ZA987623B (en) 2000-03-22
CN1197578C (zh) 2005-04-20
DK1019058T3 (da) 2006-06-12
BG104133A (en) 2000-08-31
IL134185A (en) 2005-11-20
TR200000490T2 (tr) 2000-08-21
JP3472261B2 (ja) 2003-12-02
AU8777198A (en) 1999-03-16
BR9811994A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
CY1105228T1 (el) Φαρμακευτικο αιωρημα πepιλαμβανον ημι-ενυδρη νεβιραπινη
ID27040A (id) Bentuk sediaan dengan pelepasan berpulsa dari bahan farmasi oral
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
DK0851855T3 (da) Derivater af melatonin deraf som lægemiddel
NO995533L (no) Ny fremgangsmåte for fremstilling av en farmakologisk aktiv substans
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
HUP9904065A2 (hu) Olanzapint tartalmazó bevonatos gyógyszerkészítmények
ATE249205T1 (de) Wässrige suspension zur nasalen verabreichung von loteprednol
NO962231D0 (no) Prolegemidler av paclitaxelderivater
ES2162110T3 (es) Derivados de la quinolina antimalaria.
PT1104238E (pt) Formulacao concentrada de uma suspensao contendo pirimetanilo
DE69604234T2 (de) Markerspitze
BR9612133A (pt) Derivados fosfolipídios dos ácidos fosfonocarboxílicos a produção dos mesmos assim como o uso dos mesmos como agentes farmacêuticos antivirais
FR2766088B1 (fr) Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
DK0871616T3 (da) Fremgangsmåde til fremstilling af lægemidler mod malaria
BR9813102A (pt) Derivados de ácido metilenobisfosfÈnico novos
BR0114459A (pt) Derivados substituìdos de 5-amino-1-penten-3-ol substituidos
FR2760635B1 (fr) Procede de preparation d'une composition cosmetique a base de platre et composition cosmetique ainsi obtenue
FR2791888B1 (fr) Suspension pharmaceutique buvable
UY26522A1 (es) " derivados de aminometil-fenil- ciclohexano sustituidos, procedimiento para su preparación, su uso para la preparación de medicamentos y medicamentos que contienen estos compuestos".
FR2791889B1 (fr) Suspension pharmaceutique buvable d'ibuprofene
ECSP982627A (es) Suspension farmaceutica que comprende hemihidrato de nevirapina
BR1100434B1 (pt) Uso de derivados de ácido carboxílico para a produção de drogas